{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T22:52:01Z","timestamp":1768776721926,"version":"3.49.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04501\/2020"],"award-info":[{"award-number":["UIDB\/04501\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-007628"],"award-info":[{"award-number":["POCI-01-0145-FEDER-007628"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/IC\/00051\/2019"],"award-info":[{"award-number":["UID\/IC\/00051\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/50006\/2020"],"award-info":[{"award-number":["UIDB\/50006\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["IF\/00286\/2015"],"award-info":[{"award-number":["IF\/00286\/2015"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/149138\/2019"],"award-info":[{"award-number":["SFRH\/BD\/149138\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/QUI\/00313\/2020"],"award-info":[{"award-number":["UID\/QUI\/00313\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00438-022-01866-6","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T10:14:57Z","timestamp":1645092897000},"page":"507-521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Deciphering specific miRNAs in brain tumors: a 5-miRNA signature in glioblastoma"],"prefix":"10.1007","volume":"297","author":[{"given":"Jo\u00e3o","family":"Basso","sequence":"first","affiliation":[]},{"given":"Marco G.","family":"Paggi","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Fortuna","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3424-548X","authenticated-orcid":false,"given":"Carla","family":"Vitorino","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Vitorino","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"1866_CR1","doi-asserted-by":"crossref","first-page":"175883591880116","DOI":"10.1177\/1758835918801169","volume":"10","author":"M \u00c1lvarez-Satta","year":"2018","unstructured":"\u00c1lvarez-Satta M, Matheu A (2018) Primary cilium and glioblastoma. Therapeut Adv Med Oncol 10:1758835918801169","journal-title":"Therapeut Adv Med Oncol"},{"key":"1866_CR2","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1007\/s13277-015-4654-x","volume":"37","author":"A Besse","year":"2016","unstructured":"Besse A, Sana J, Lakomy R, Kren L, Fadrus P, Smrcka M, Hermanova M, Jancalek R, Reguli S, Lipina R (2016) MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response. Tumor Biol 37:7719\u20137727","journal-title":"Tumor Biol"},{"key":"1866_CR3","first-page":"7","volume":"2018","author":"N Borcherding","year":"2018","unstructured":"Borcherding N, Bormann NL, Voigt AP, Zhang W (2018) TRGAted: a web tool for survival analysis using protein data in the Cancer Genome Atlas. F1000Research 2018:7","journal-title":"F1000Research"},{"key":"1866_CR4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH (2013) The somatic genomic landscape of glioblastoma. Cell 155:462\u2013477","journal-title":"Cell"},{"key":"1866_CR5","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/gt.2011.50","volume":"18","author":"JA Broderick","year":"2011","unstructured":"Broderick JA, Zamore PD (2011) MicroRNA therapeutics. Gene Ther 18:1104\u20131110","journal-title":"Gene Ther"},{"key":"1866_CR6","first-page":"65","volume":"15","author":"H Budak","year":"2016","unstructured":"Budak H, Bulut R, Kantar M, Alptekin B (2016) MicroRNA nomenclature and the need for a revised naming prescription. Brief Funct Genomics 15:65\u201371","journal-title":"Brief Funct Genomics"},{"key":"1866_CR7","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.3390\/ijms21061950","volume":"21","author":"A Buruian\u0103","year":"2020","unstructured":"Buruian\u0103 A, Florian \u0218I, Florian AI, Timi\u0219 T-L, Mihu CM, Micl\u0103u\u0219 M, O\u0219an S, Hrap\u0219a I, Cataniciu RC, Farca\u0219 M (2020) The roles of miRNA in glioblastoma tumor cell communication: diplomatic and aggressive negotiations. Int J Mol Sci 21:1950","journal-title":"Int J Mol Sci"},{"key":"1866_CR8","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"Cancer Genome Atlas Research Network","year":"2008","unstructured":"Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061","journal-title":"Nature"},{"key":"1866_CR9","first-page":"911","volume":"42","author":"S Candido","year":"2019","unstructured":"Candido S, Lupo G, Pennisi M, Basile MS, Anfuso CD, Petralia MC, Gattuso G, Vivarelli S, Spandidos DA, Libra M (2019) The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer\u2019s disease. Oncol Rep 42:911\u2013922","journal-title":"Oncol Rep"},{"key":"1866_CR10","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1074\/mcp.RA118.001260","volume":"18","author":"M-JM Chen","year":"2019","unstructured":"Chen M-JM, Li J, Wang Y, Akbani R, Lu Y, Mills GB, Liang H (2019) TCPA v3. 0: an integrative platform to explore the pan-cancer analysis of functional proteomic data. Mol Cell Proteomics 18:S15\u2013S25","journal-title":"Mol Cell Proteomics"},{"key":"1866_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ebiom.2019.04.010","volume":"43","author":"C-A Chu","year":"2019","unstructured":"Chu C-A, Lee C-T, Lee J-C, Wang Y-W, Huang C-T, Lan S-H, Lin P-C, Lin B-W, Tian Y-F, Liu H-S (2019) MiR-338-5p promotes metastasis of colorectal cancer by inhibition of phosphatidylinositol 3-kinase, catalytic subunit type 3-mediated autophagy pathway. EBioMedicine 43:270\u2013281","journal-title":"EBioMedicine"},{"key":"1866_CR12","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3390\/cancers12061558","volume":"12","author":"C Cirotti","year":"2020","unstructured":"Cirotti C, Contadini C, Baril\u00e0 D (2020) Src kinase in glioblastoma news from an old acquaintance. Cancers 12:1558","journal-title":"Cancers"},{"key":"1866_CR13","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","volume":"33","author":"JR Conway","year":"2017","unstructured":"Conway JR, Lex A, Gehlenborg N (2017) UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics 33:2938\u20132940","journal-title":"Bioinformatics"},{"key":"1866_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1752-0509-4-163","volume":"4","author":"H Dong","year":"2010","unstructured":"Dong H, Luo L, Hong S, Siu H, Xiao Y, Jin L, Chen R, Xiong M (2010) Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma. BMC Syst Biol 4:163","journal-title":"BMC Syst Biol"},{"key":"1866_CR15","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3389\/fncel.2014.00418","volume":"8","author":"LG Dubois","year":"2014","unstructured":"Dubois LG, Campanati L, Righy C, D\u2019Andrea-Meira I, Porto-Carreiro I, Pereira CM, Bal\u00e7a-Silva J, Kahn SA, DosSantos MF, Oliveira MdAR (2014) Gliomas and the vascular fragility of the blood brain barrier. Front Cell Neurosci 8:418","journal-title":"Front Cell Neurosci"},{"key":"1866_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41698-017-0044-8","volume":"2","author":"S Ebrahimkhani","year":"2018","unstructured":"Ebrahimkhani S, Vafaee F, Hallal S, Wei H, Lee MYT, Young PE, Satgunaseelan L, Beadnall H, Barnett MH, Shivalingam B (2018) Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis. NPJ Precision Oncol 2:1\u20139","journal-title":"NPJ Precision Oncol"},{"key":"1866_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3892\/br.2016.747","volume":"5","author":"Y-H Feng","year":"2016","unstructured":"Feng Y-H, Tsao C-J (2016) Emerging role of microRNA-21 in cancer. Biomed Rep 5:395\u2013402","journal-title":"Biomed Rep"},{"key":"1866_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cels.2019.06.006","volume":"9","author":"GF Gao","year":"2019","unstructured":"Gao GF, Parker JS, Reynolds SM, Silva TC, Wang L-B, Zhou W, Akbani R, Bailey M, Balu S, Berman BP (2019) Before and after: comparison of legacy and harmonized TCGA genomic data commons\u2019 data. Cell Syst 9:24\u201334","journal-title":"Cell Syst"},{"key":"1866_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.wneu.2020.03.128","volume":"138","author":"CM Garcia","year":"2020","unstructured":"Garcia CM, Toms SA (2020) The role of circulating MicroRNA in glioblastoma liquid biopsy. World Neurosurg 138:425\u2013435","journal-title":"World Neurosurg"},{"key":"1866_CR20","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.molmed.2006.10.006","volume":"12","author":"R Garzon","year":"2006","unstructured":"Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM (2006) MicroRNA expression and function in cancer. Trends Mol Med 12:580\u2013587","journal-title":"Trends Mol Med"},{"key":"1866_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00066-005-1304-z","volume":"181","author":"MW Gross","year":"2005","unstructured":"Gross MW, Kraus A, Nashwan K, Mennel H-D, Engenhart-Cabillic R, Schlegel J (2005) Expression of p53 and p21 in primary glioblastomas. Strahlenther Onkol 181:164\u2013171","journal-title":"Strahlenther Onkol"},{"key":"1866_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mam.2019.09.004","volume":"70","author":"D Gulei","year":"2019","unstructured":"Gulei D, Raduly L, Broseghini E, Ferracin M, Berindan-Neagoe I (2019) The extensive role of miR-155 in malignant and non-malignant diseases. Mol Aspects Med 70:33\u201356","journal-title":"Mol Aspects Med"},{"key":"1866_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s12032-013-0557-0","volume":"30","author":"Z He","year":"2013","unstructured":"He Z, Cen D, Luo X, Li D, Li P, Liang L, Meng Z (2013) Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor. Med Oncol 30:557","journal-title":"Med Oncol"},{"key":"1866_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/15476286.2019.1667741","volume":"17","author":"F Heinicke","year":"2020","unstructured":"Heinicke F, Zhong X, Zucknick M, Breidenbach J, Sundaram AY, Fl\u00e5m TS, Leithaug M, Dalland M, Farmer A, Henderson JM (2020) Systematic assessment of commercially available low-input miRNA library preparation kits. RNA Biol 17:75\u201386","journal-title":"RNA Biol"},{"key":"1866_CR25","doi-asserted-by":"publisher","first-page":"e0125791","DOI":"10.1371\/journal.pone.0125791","volume":"10","author":"A Herman","year":"2015","unstructured":"Herman A, Gruden K, Blejec A, Podpe\u010dan V, Motaln H, Ro\u017eman P, Hren M, Zupan\u010di\u010d K, Veber M, Verbov\u0161ek U (2015) Analysis of glioblastoma patients\u2019 plasma revealed the presence of microRNAs with a prognostic impact on survival and those of viral origin. PLoS ONE 10:e0125791","journal-title":"PLoS ONE"},{"key":"1866_CR26","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/aps.2017.173","volume":"39","author":"S-w Huang","year":"2018","unstructured":"Huang S-w, Zhong L, Shi J (2018) MicroRNAs as biomarkers for human glioblastoma: progress and potential. Acta Pharmacol Sin 39:1405\u20131413","journal-title":"Acta Pharmacol Sin"},{"key":"1866_CR27","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1073\/pnas.1217602110","volume":"110","author":"A Iwanami","year":"2013","unstructured":"Iwanami A, Gini B, Zanca C, Matsutani T, Assuncao A, Nael A, Dang J, Yang H, Zhu S, Kohyama J (2013) PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies. Proc Natl Acad Sci 110:4339\u20134344","journal-title":"Proc Natl Acad Sci"},{"key":"1866_CR28","first-page":"2021","volume":"11","author":"J-M Jung","year":"1995","unstructured":"Jung J-M, Bruner JM, Ruan S, Langford LA, Kyritsis AP, Kobayashi T, Levin VA, Zhang W (1995) Increased levels of p21WAF1\/Cip1 in human brain tumors. Oncogene 11:2021\u20132028","journal-title":"Oncogene"},{"key":"1866_CR29","doi-asserted-by":"publisher","first-page":"173144","DOI":"10.1016\/j.ejphar.2020.173144","volume":"2020","author":"S Khalighfard","year":"2020","unstructured":"Khalighfard S, Kalhori MR, Haddad P, Khori V, Alizadeh AM (2020) Enhancement of resistance to chemo-radiation by hsa-miR-1290 expression in glioblastoma cells. Eur J Pharmacol 2020:173144","journal-title":"Eur J Pharmacol"},{"key":"1866_CR30","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3390\/cancers12051099","volume":"12","author":"A Kirstein","year":"2020","unstructured":"Kirstein A, Schmid TE, Combs SE (2020) The role of miRNA for the treatment of MGMT unmethylated glioblastoma multiforme. Cancers 12:1099","journal-title":"Cancers"},{"key":"1866_CR31","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1093\/brain\/awm204","volume":"130","author":"D Krex","year":"2007","unstructured":"Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G, Network ftGG (2007) Long-term survival with glioblastoma multiforme. Brain 130:2596\u20132606","journal-title":"Brain"},{"key":"1866_CR32","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.biopha.2017.01.137","volume":"89","author":"D Lei","year":"2017","unstructured":"Lei D, Zhang F, Yao D, Xiong N, Jiang X, Zhao H (2017) MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1. Biomed Pharmacother 89:957\u2013965","journal-title":"Biomed Pharmacother"},{"key":"1866_CR33","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/onc.2014.98","volume":"34","author":"X Li","year":"2015","unstructured":"Li X, Liu Y, Granberg KJ, Wang Q, Moore LM, Ji P, Gumin J, Sulman EP, Calin GA, Haapasalo H (2015) Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene 34:1619\u20131628","journal-title":"Oncogene"},{"key":"1866_CR34","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/carcin\/bgy189","volume":"40","author":"W-C Lin","year":"2019","unstructured":"Lin W-C, Chen L-H, Hsieh Y-C, Yang P-W, Lai L-C, Chuang EY, Lee J-M, Tsai M-H (2019) miR-338-5p inhibits cell proliferation, colony formation, migration and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2. Carcinogenesis 40:883\u2013892","journal-title":"Carcinogenesis"},{"key":"1866_CR35","first-page":"39","volume":"2019","author":"K Liu","year":"2019","unstructured":"Liu K, Fu Q, Liu Y, Wang C (2019) An integrative bioinformatics analysis of microarray data for identifying hub genes as diagnostic biomarkers of preeclampsia. Biosci Rep 2019:39","journal-title":"Biosci Rep"},{"key":"1866_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fnmol.2019.00066","volume":"12","author":"W Lou","year":"2019","unstructured":"Lou W, Ding B, Xu L, Fan W (2019) Construction of potential glioblastoma multiforme-related miRNA-mRNA regulatory network. Front Mol Neurosci 12:66","journal-title":"Front Mol Neurosci"},{"key":"1866_CR37","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820","journal-title":"Acta Neuropathol"},{"key":"1866_CR38","doi-asserted-by":"publisher","first-page":"e0189452","DOI":"10.1371\/journal.pone.0189452","volume":"13","author":"C Ma","year":"2018","unstructured":"Ma C, Nguyen HP, Luwor RB, Stylli SS, Gogos A, Paradiso L, Kaye AH, Morokoff AP (2018a) A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker. PLoS ONE 13:e0189452","journal-title":"PLoS ONE"},{"key":"1866_CR39","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s00432-018-2745-y","volume":"144","author":"X-L Ma","year":"2018","unstructured":"Ma X-L, Shang F, Ni W, Zhu J, Luo B, Zhang Y-Q (2018b) MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1. J Cancer Res Clin Oncol 144:2351\u20132366","journal-title":"J Cancer Res Clin Oncol"},{"key":"1866_CR40","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3892\/ijo.2017.4122","volume":"51","author":"K Mao","year":"2017","unstructured":"Mao K, Lei D, Zhang H, You C (2017) MicroRNA-485 inhibits malignant biological behaviour of glioblastoma cells by directly targeting PAK4. Int J Oncol 51:1521\u20131532","journal-title":"Int J Oncol"},{"key":"1866_CR41","doi-asserted-by":"publisher","first-page":"45764","DOI":"10.18632\/oncotarget.9945","volume":"7","author":"M Niyazi","year":"2016","unstructured":"Niyazi M, Pitea A, Mittelbronn M, Steinbach J, Sticht C, Zehentmayr F, Piehlmaier D, Zitzelsberger H, Ganswindt U, R\u00f6del C (2016) A 4-miRNA signature predicts the therapeutic outcome of glioblastoma. Oncotarget 7:45764","journal-title":"Oncotarget"},{"key":"1866_CR42","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro Oncol 21:v1\u2013v100","journal-title":"Neuro Oncol"},{"key":"1866_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sigtrans.2017.40","volume":"2","author":"JR Pearson","year":"2017","unstructured":"Pearson JR, Regad T (2017) Targeting cellular pathways in glioblastoma multiforme. Signal Transduct Target Ther 2:1\u201311","journal-title":"Signal Transduct Target Ther"},{"key":"1866_CR44","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.molonc.2015.03.007","volume":"9","author":"M Piwecka","year":"2015","unstructured":"Piwecka M, Rolle K, Belter A, Barciszewska AM, \u017bywicki M, Michalak M, Nowak S, Naskr\u0119t-Barciszewska MZ, Barciszewski J (2015) Comprehensive analysis of microRNA expression profile in malignant glioma tissues. Mol Oncol 9:1324\u20131340","journal-title":"Mol Oncol"},{"key":"1866_CR45","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.wneu.2017.04.053","volume":"103","author":"M Rapp","year":"2017","unstructured":"Rapp M, Baernreuther J, Turowski B, Steiger H-J, Sabel M, Kamp MA (2017) Recurrence pattern analysis of primary glioblastoma. World Neurosurg 103:733\u2013740","journal-title":"World Neurosurg"},{"key":"1866_CR46","doi-asserted-by":"publisher","first-page":"104550","DOI":"10.1016\/j.yexmp.2020.104550","volume":"2020","author":"O Rezaei","year":"2020","unstructured":"Rezaei O, Honarmand K, Nateghinia S, Taheri M, Ghafouri-Fard S (2020) miRNA signature in glioblastoma: potential biomarkers and therapeutic targets. Exp Mol Pathol 2020:104550","journal-title":"Exp Mol Pathol"},{"key":"1866_CR47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1471-4159.2011.07307.x","volume":"118","author":"P Roth","year":"2011","unstructured":"Roth P, Wischhusen J, Happold C, Chandran PA, Hofer S, Eisele G, Weller M, Keller A (2011) A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem 118:449\u2013457","journal-title":"J Neurochem"},{"key":"1866_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3892\/ijo.2014.2712","volume":"46","author":"Y Sato-Kuwabara","year":"2015","unstructured":"Sato-Kuwabara Y, Melo SA, Soares FA, Calin GA (2015) The fusion of two worlds: non-coding RNAs and extracellular vesicles-diagnostic and therapeutic implications. Int J Oncol 46:17\u201327","journal-title":"Int J Oncol"},{"key":"1866_CR49","first-page":"1938","volume":"18","author":"SK Shaji","year":"2019","unstructured":"Shaji SK, Sunilkumar D, Mahalakshmi N, Kumar GB, Nair BG (2019) Analysis of microarray data for identification of key microRNA signatures in glioblastoma multiforme. Oncol Lett 18:1938\u20131948","journal-title":"Oncol Lett"},{"key":"1866_CR50","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1002\/cam4.775","volume":"5","author":"A Shea","year":"2016","unstructured":"Shea A, Harish V, Afzal Z, Chijioke J, Kedir H, Dusmatova S, Roy A, Ramalinga M, Harris B, Blancato J, Verma M, Kumar D (2016) MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics. Cancer Med 5:1917\u20131946","journal-title":"Cancer Med"},{"key":"1866_CR51","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/jcm5040042","volume":"5","author":"J Shi","year":"2016","unstructured":"Shi J (2016) Considering exosomal miR-21 as a biomarker for cancer. J Clin Med 5:42","journal-title":"J Clin Med"},{"key":"1866_CR52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/B978-0-12-819666-3.00005-5","volume-title":"Advances and avenues in the development of novel carriers for bioactives and biological agents","author":"J Silva","year":"2020","unstructured":"Silva J, Basso J, Mendes M, Sousa J, Pais A, Vitorino C (2020) Tailoring drug and gene codelivery nanosystems for glioblastoma treatment. In: Singh MR, Singh D, Kanwar JR, Chauhan NS (eds) Advances and avenues in the development of novel carriers for bioactives and biological agents. Elsevier, Berlin, pp 141\u2013182"},{"key":"1866_CR53","doi-asserted-by":"publisher","first-page":"e17438","DOI":"10.1371\/journal.pone.0017438","volume":"6","author":"S Srinivasan","year":"2011","unstructured":"Srinivasan S, Patric IRP, Somasundaram K (2011) A ten-microRNA expression signature predicts survival in glioblastoma. PLoS ONE 6:e17438","journal-title":"PLoS ONE"},{"key":"1866_CR54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fgene.2016.00011","volume":"7","author":"N Stoicea","year":"2016","unstructured":"Stoicea N, Du A, Lakis DC, Tipton C, Arias-Morales CE, Bergese SD (2016) The MiRNA journey from theory to practice as a CNS biomarker. Front Genet 7:11","journal-title":"Front Genet"},{"key":"1866_CR55","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"1866_CR56","doi-asserted-by":"publisher","first-page":"e2714","DOI":"10.1038\/cddis.2017.134","volume":"8","author":"R Sun","year":"2017","unstructured":"Sun R, Liu Z, Tong D, Yang Y, Guo B, Wang X, Zhao L, Huang C (2017) miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a\/\u03b2-catenin signaling in the development of gastric cancer. Cell Death Dis 8:e2714\u2013e2714","journal-title":"Cell Death Dis"},{"key":"1866_CR57","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P (2019) STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47:D607\u2013D613","journal-title":"Nucleic Acids Res"},{"key":"1866_CR58","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z (2019) GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 47:W556\u2013W560","journal-title":"Nucleic Acids Res"},{"key":"1866_CR59","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, Boutselakis H, Cole CG, Creatore C, Dawson E (2019) COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res 47:D941\u2013D947","journal-title":"Nucleic Acids Res"},{"key":"1866_CR60","doi-asserted-by":"publisher","first-page":"D360","DOI":"10.1093\/nar\/gkx1144","volume":"46","author":"T Tokar","year":"2018","unstructured":"Tokar T, Pastrello C, Rossos AE, Abovsky M, Hauschild A-C, Tsay M, Lu R, Jurisica I (2018) mirDIP 4.1\u2014integrative database of human microRNA target predictions. Nucleic Acids Res 46:D360\u2013D370","journal-title":"Nucleic Acids Res"},{"key":"1866_CR61","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1093\/nar\/gkr254","volume":"39","author":"A Turchinovich","year":"2011","unstructured":"Turchinovich A, Weiz L, Langheinz A, Burwinkel B (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39:7223\u20137233","journal-title":"Nucleic Acids Res"},{"key":"1866_CR62","doi-asserted-by":"publisher","first-page":"7211","DOI":"10.3390\/ijms21197211","volume":"21","author":"T Tzaridis","year":"2020","unstructured":"Tzaridis T, Reiners KS, Weller J, Bachurski D, Sch\u00e4fer N, Schaub C, Hallek M, Scheffler B, Glas M, Herrlinger U (2020) Analysis of serum miRNA in glioblastoma patients: CD44-based enrichment of extracellular vesicles enhances specificity for the prognostic signature. Int J Mol Sci 21:7211","journal-title":"Int J Mol Sci"},{"key":"1866_CR63","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.7150\/jca.21248","volume":"9","author":"V Vashishtha","year":"2018","unstructured":"Vashishtha V, Jinghan N, Yadav AK (2018) Antagonistic role of GSK3 isoforms in glioma survival. J Cancer 9:1846","journal-title":"J Cancer"},{"key":"1866_CR64","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ncb2210","volume":"13","author":"KC Vickers","year":"2011","unstructured":"Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13:423\u2013433","journal-title":"Nat Cell Biol"},{"key":"1866_CR65","doi-asserted-by":"publisher","first-page":"35893","DOI":"10.18632\/oncotarget.5651","volume":"6","author":"S Wang","year":"2015","unstructured":"Wang S, Mo Y, Midorikawa K, Zhang Z, Huang G, Ma N, Zhao W, Hiraku Y, Oikawa S, Murata M (2015) The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L. Oncotarget 6:35893","journal-title":"Oncotarget"},{"key":"1866_CR66","doi-asserted-by":"publisher","first-page":"e0184969","DOI":"10.1371\/journal.pone.0184969","volume":"12","author":"Z-Q Wang","year":"2017","unstructured":"Wang Z-Q, Zhang M-Y, Deng M-L, Weng N-Q, Wang H-Y, Wu S-X (2017) Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma. PLoS ONE 12:e0184969","journal-title":"PLoS ONE"},{"key":"1866_CR67","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s40263-017-0456-6","volume":"31","author":"M Westphal","year":"2017","unstructured":"Westphal M, Maire CL, Lamszus K (2017) EGFR as a target for glioblastoma treatment: an unfulfilled promise. CNS Drugs 31:723\u2013735","journal-title":"CNS Drugs"},{"key":"1866_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-57659-7","volume":"10","author":"K Wright","year":"2020","unstructured":"Wright K, de Silva K, Purdie AC, Plain KM (2020) Comparison of methods for miRNA isolation and quantification from ovine plasma. Sci Rep 10:1\u201311","journal-title":"Sci Rep"},{"key":"1866_CR69","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.bbrc.2014.10.047","volume":"453","author":"Z Xu","year":"2014","unstructured":"Xu Z, Zeng X, Tian D, Xu H, Cai Q, Wang J, Chen Q (2014) MicroRNA-383 inhibits anchorage-independent growth and induces cell cycle arrest of glioma cells by targeting CCND1. Biochem Biophys Res Commun 453:833\u2013838","journal-title":"Biochem Biophys Res Commun"},{"key":"1866_CR70","doi-asserted-by":"publisher","first-page":"7743","DOI":"10.1007\/s13277-015-3378-2","volume":"36","author":"D Xu","year":"2015","unstructured":"Xu D, Ma P, Gao G, Gui Y, Niu X, Jin B (2015) MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells. Tumor Biol 36:7743\u20137753","journal-title":"Tumor Biol"},{"key":"1866_CR71","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12859-018-2531-5","volume":"19","author":"T Xu","year":"2018","unstructured":"Xu T, Su N, Liu L, Zhang J, Wang H, Zhang W, Gui J, Yu K, Li J, Le TD (2018) miRBaseConverter: an R\/Bioconductor package for converting and retrieving miRNA name, accession, sequence and family information in different versions of miRBase. BMC Bioinf 19:179\u2013188","journal-title":"BMC Bioinf"},{"key":"1866_CR72","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765\u2013773","journal-title":"N Engl J Med"},{"key":"1866_CR73","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1002\/jcp.26381","volume":"233","author":"L Yan","year":"2018","unstructured":"Yan L, Cai K, Sun K, Gui J, Liang J (2018) MiR-1290 promotes proliferation, migration, and invasion of glioma cells by targeting LHX6. J Cell Physiol 233:6621\u20136629","journal-title":"J Cell Physiol"},{"key":"1866_CR74","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ijc.27657","volume":"132","author":"C Yang","year":"2013","unstructured":"Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F, Wang J, Li L, Zhou X, Li N (2013) Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Int J Cancer 132:116\u2013127","journal-title":"Int J Cancer"},{"key":"1866_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-13-280","volume":"13","author":"FL Yong","year":"2013","unstructured":"Yong FL, Law CW, Wang CW (2013) Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer. BMC Cancer 13:1\u201310","journal-title":"BMC Cancer"},{"key":"1866_CR76","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/cncr.27826","volume":"119","author":"W Zhang","year":"2013","unstructured":"Zhang W, Zhang J, Yan W, You G, Bao Z, Li S, Kang C, Jiang C, You Y, Zhang Y (2013) Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme. Cancer 119:814\u2013824","journal-title":"Cancer"},{"key":"1866_CR77","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","volume":"13","author":"J Zhang","year":"2015","unstructured":"Zhang J, Li S, Li L, Li M, Guo C, Yao J, Mi S (2015) Exosome and exosomal microRNA: trafficking, sorting, and function. Genom Proteom Bioinf 13:17\u201324","journal-title":"Genom Proteom Bioinf"},{"key":"1866_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-017-0003-4","volume":"3","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Chen J, Wei W, Qi X, Li C, Ren J (2018) The dual-inhibitory effect of miR-338-5p on the multidrug resistance and cell growth of hepatocellular carcinoma. Signal Transduct Target Ther 3:1\u201310","journal-title":"Signal Transduct Target Ther"},{"key":"1866_CR79","first-page":"307","volume":"18","author":"P Zhou","year":"2019","unstructured":"Zhou P, Li X (2019) Serum miR-338-5p has potential for use as a tumor marker for retinoblastoma. Oncol Lett 18:307\u2013313","journal-title":"Oncol Lett"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-022-01866-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-022-01866-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-022-01866-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T22:13:01Z","timestamp":1668031981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-022-01866-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1866"],"URL":"https:\/\/doi.org\/10.1007\/s00438-022-01866-6","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"assertion":[{"value":"23 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}